Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132058) titled 'Immune Monitoring-Guided Individualized Tacrolimus Therapy in Renal Transplant Recipients: An Observational Study and PK/PD Modeling' on Sept. 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhongnan Hospital of Wuhan University
Condition:
Complications related to immune imbalance after kidney transplantation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-09
Target Sample Size: Observation Group of Complications Related to Immune Imbalance after Kidney Transplantation:50;
Countries of Recruitment:
China
To know more, visit https://www.c...